FDA Physician Labeling Rule Withdrawn From OMB
This article was originally published in The Pink Sheet Daily
Executive Summary
Final rule has drawn opposition from industry, especially the addition of a "highlights" section. FDA is proposing staggered implementation to lower the costs of the labeling redesign. Rule would also affect DTC ads. Office of Management & Budget received the reg in January.
You may also be interested in...
Physician Labeling Final Rule Targeted For Release In May
FDA expects to release the physician labeling final rule by the end of May, according to HHS' semi-annual "unified agenda" published in the May 16 Federal Register
Physician Labeling Final Rule Targeted For Release In May
FDA expects to release the physician labeling final rule by the end of May, according to HHS' semi-annual "unified agenda" published in the May 16 Federal Register
Drug Labeling Rule Returns To OMB
FDA's physician labeling rule has been resubmitted to the White House Office of Management & Budget